Ma Tianheng, Wang Honggang, Dai Weijie, Shen Peng, Zhang Jialing, Xie Rui
Department of Gastroenterology, The Affiliated Huai'an No 1 People's Hospital of Nanjing Medical University, No.1 Huanghe West Road, Huai'an, 223300, Jiangsu, China.
Sci Rep. 2025 May 28;15(1):18628. doi: 10.1038/s41598-025-03046-z.
Small intestine tumors, though rare, have shown a concerning increase in incidence and mortality in recent years. This study aimed to investigate the historical trends in histological composition and causes of death among patients with small intestine tumors using the SEER database. A total of 18,234 patients diagnosed with primary small intestine cancer from 1992 to 2018 were included in this study. Demographic details, tumor characteristics, treatment modalities, and outcomes were collected. Cause-specific mortality was analyzed using Fine and Gray regression, with non-small intestine-specific deaths considered as competing risks. Small intestine-specific deaths were the leading cause of mortality, with adenocarcinoma and carcinoid tumors being the most common histological types. Heart disease emerged as a significant cause of death following diagnosis, surpassing small intestine-specific deaths after 5-6 years. The study revealed variations in mortality causes across histological subtypes and identified risk factors for small intestine-specific mortality, including age, tumor site, grade, and treatment modalities. The findings highlight the substantial impact of heart disease on the long-term survival of patients with small intestine tumors. This underscores the potential benefits of adopting comprehensive management strategies that integrate oncological and cardiological care to improve survival rates and quality of life. A multidisciplinary approach in oncocardiology may help address the complex needs of these patients and optimize clinical outcomes.
小肠肿瘤虽然罕见,但近年来其发病率和死亡率呈令人担忧的上升趋势。本研究旨在利用监测、流行病学和最终结果(SEER)数据库调查小肠肿瘤患者的组织学构成历史趋势和死亡原因。本研究纳入了1992年至2018年期间共18234例诊断为原发性小肠癌的患者。收集了人口统计学细节、肿瘤特征、治疗方式和结局。使用Fine和Gray回归分析特定病因死亡率,将非小肠特异性死亡视为竞争风险。小肠特异性死亡是主要死因,腺癌和类癌肿瘤是最常见的组织学类型。心脏病在诊断后成为重要死因,5至6年后超过小肠特异性死亡。该研究揭示了不同组织学亚型的死亡原因差异,并确定了小肠特异性死亡的危险因素,包括年龄、肿瘤部位、分级和治疗方式。研究结果突出了心脏病对小肠肿瘤患者长期生存的重大影响。这强调了采用综合管理策略的潜在益处,该策略整合肿瘤学和心脏病学护理以提高生存率和生活质量。肿瘤心脏病学的多学科方法可能有助于满足这些患者的复杂需求并优化临床结局。